Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 1
1951 2
1954 1
1957 2
1959 2
1960 2
1961 5
1962 1
1965 1
1966 1
1968 2
1969 2
1970 2
1972 4
1974 1
1976 3
1979 2
1980 3
1981 2
1982 1
1983 1
1984 2
1985 1
1986 2
1987 3
1988 1
1989 2
1990 2
1991 5
1992 11
1993 7
1994 3
1995 3
1996 9
1997 3
1998 5
1999 8
2000 6
2001 6
2002 5
2003 6
2004 11
2005 6
2006 13
2007 5
2008 14
2009 8
2010 13
2011 16
2012 14
2013 7
2014 7
2015 11
2016 5
2017 15
2018 8
2019 10
2020 19
2021 20
2022 14
2023 17
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

345 results

Results by year

Filters applied: . Clear all
Page 1
Angiotensin Receptor-Neprilysin Inhibition in Acute Myocardial Infarction.
Pfeffer MA, Claggett B, Lewis EF, Granger CB, Køber L, Maggioni AP, Mann DL, McMurray JJV, Rouleau JL, Solomon SD, Steg PG, Berwanger O, Cikes M, De Pasquale CG, East C, Fernandez A, Jering K, Landmesser U, Mehran R, Merkely B, Vaghaiwalla Mody F, Petrie MC, Petrov I, Schou M, Senni M, Sim D, van der Meer P, Lefkowitz M, Zhou Y, Gong J, Braunwald E; PARADISE-MI Investigators and Committees. Pfeffer MA, et al. N Engl J Med. 2021 Nov 11;385(20):1845-1855. doi: 10.1056/NEJMoa2104508. N Engl J Med. 2021. PMID: 34758252 Clinical Trial.
Effect of Sacubitril/Valsartan vs Standard Medical Therapies on Plasma NT-proBNP Concentration and Submaximal Exercise Capacity in Patients With Heart Failure and Preserved Ejection Fraction: The PARALLAX Randomized Clinical Trial.
Pieske B, Wachter R, Shah SJ, Baldridge A, Szeczoedy P, Ibram G, Shi V, Zhao Z, Cowie MR; PARALLAX Investigators and Committee members. Pieske B, et al. JAMA. 2021 Nov 16;326(19):1919-1929. doi: 10.1001/jama.2021.18463. JAMA. 2021. PMID: 34783839 Free PMC article. Clinical Trial.
Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes.
Holman RR, Bethel MA, Mentz RJ, Thompson VP, Lokhnygina Y, Buse JB, Chan JC, Choi J, Gustavson SM, Iqbal N, Maggioni AP, Marso SP, Öhman P, Pagidipati NJ, Poulter N, Ramachandran A, Zinman B, Hernandez AF; EXSCEL Study Group. Holman RR, et al. N Engl J Med. 2017 Sep 28;377(13):1228-1239. doi: 10.1056/NEJMoa1612917. Epub 2017 Sep 14. N Engl J Med. 2017. PMID: 28910237 Free PMC article. Clinical Trial.
Effect of Sotagliflozin on Total Hospitalizations in Patients With Type 2 Diabetes and Worsening Heart Failure : A Randomized Trial.
Szarek M, Bhatt DL, Steg PG, Cannon CP, Leiter LA, McGuire DK, Lewis JB, Riddle MC, Voors AA, Metra M, Lund LH, Komajda M, Testani JM, Wilcox CS, Ponikowski P, Lopes RD, Banks P, Tesfaye E, Ezekowitz JA, Verma S, Pitt B; SOLOIST-WHF committees and investigators. Szarek M, et al. Ann Intern Med. 2021 Aug;174(8):1065-1072. doi: 10.7326/M21-0651. Epub 2021 Jun 22. Ann Intern Med. 2021. PMID: 34152828 Clinical Trial.
Acquired Digital Fibrokeratoma.
Navea OV, Navea MB, De la Fuente R. Navea OV, et al. Among authors: de la fuente r. Cureus. 2023 Oct 30;15(10):e47997. doi: 10.7759/cureus.47997. eCollection 2023 Oct. Cureus. 2023. PMID: 38034253 Free PMC article.
X-linked hypophosphatemia and growth.
Fuente R, Gil-Peña H, Claramunt-Taberner D, Hernández O, Fernández-Iglesias A, Alonso-Durán L, Rodríguez-Rubio E, Santos F. Fuente R, et al. Rev Endocr Metab Disord. 2017 Mar;18(1):107-115. doi: 10.1007/s11154-017-9408-1. Rev Endocr Metab Disord. 2017. PMID: 28130634 Free article. Review.
Hypophosphatemia and growth.
Santos F, Fuente R, Mejia N, Mantecon L, Gil-Peña H, Ordoñez FA. Santos F, et al. Among authors: fuente r. Pediatr Nephrol. 2013 Apr;28(4):595-603. doi: 10.1007/s00467-012-2364-9. Epub 2012 Nov 22. Pediatr Nephrol. 2013. PMID: 23179196 Review.
Dual angiotensin receptor and neprilysin inhibition as an alternative to angiotensin-converting enzyme inhibition in patients with chronic systolic heart failure: rationale for and design of the Prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure trial (PARADIGM-HF).
McMurray JJ, Packer M, Desai AS, Gong J, Lefkowitz MP, Rizkala AR, Rouleau J, Shi VC, Solomon SD, Swedberg K, Zile MR; PARADIGM-HF Committees and Investigators. McMurray JJ, et al. Eur J Heart Fail. 2013 Sep;15(9):1062-73. doi: 10.1093/eurjhf/hft052. Epub 2013 Apr 5. Eur J Heart Fail. 2013. PMID: 23563576 Free PMC article. Clinical Trial.
Genomic Signature in Evolutionary Biology: A Review.
de la Fuente R, Díaz-Villanueva W, Arnau V, Moya A. de la Fuente R, et al. Biology (Basel). 2023 Feb 16;12(2):322. doi: 10.3390/biology12020322. Biology (Basel). 2023. PMID: 36829597 Free PMC article. Review.
Migration of highly-skilled workers: personal perspectives.
Oleribe OO, de la Fuente RA. Oleribe OO, et al. Among authors: de la fuente ra. Pan Afr Med J. 2022 Apr 12;41:292. doi: 10.11604/pamj.2022.41.292.34644. eCollection 2022. Pan Afr Med J. 2022. PMID: 35855032 Free PMC article.
345 results